CSIMarket Company Name, Ticker, Suppliers, else..
 

International Stem Cell Corporation  (ISCO)

International Stem Cell's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

ISCO Sales vs. its Competitors Q2 2026


Comparing the current results to its competitors, International Stem Cell reported Revenue increase in the 2 quarter 2026 by 9.32 % year on year, while most of its competitors have experienced contraction in revenues by -75.44 %, achieved in the same quarter.

• List of ISCO Competitors





Revenue Growth Comparisons




Net Income Comparison

International Stem Cell Corporation, faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<<  ISCO Stock Performance Comparisons





  

Overall company Market Share Q2 2026
With revenue growth of 9.32 % within Overall company, International Stem Cell Corporation achieved improvement in market share, within Overall company to approximately 56.83 %.
<<  More on ISCO Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of International Stem Cell Corporation




Moleculin Biotech Inc
Share Performance



+16.29%
Over The Past 5 Days
Moleculin Biotech Inc
Profile

Moleculin Biotech Inc is a biopharmaceutical company that develops innovative cancer therapies by targeting key enzymes and signaling pathways involved in the progression of tumors. Their business model revolves around conducting preclinical and clinical trials to advance their drug candidates, with a focus on maximizing therapeutic impact and commercial potential.

More about Moleculin Biotech Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 4.261 mill. $ - mill. $ -42.162 mill.


Larimar Therapeutics Inc
Share Performance



-2.04%
30 Days
Larimar Therapeutics Inc
Profile

Larimar Therapeutics Inc's business model revolves around the development and commercialization of innovative therapeutics for the treatment of rare and serious genetic diseases.

More about Larimar Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ - mill. $ - mill. $ -172.605 mill.


Lipocine Inc
Share Performance



+10.80%
30 Days
Lipocine Inc
Profile

Lipocine Inc is a pharmaceutical company focused on developing oral drug delivery systems for hormone therapeutics. Their business model involves conducting research and development to create innovative products that address unmet medical needs in areas such as testosterone replacement therapy and hypogonadism. The company aims to commercialize these proprietary drug candidates and collaborate with industry partners to enhance their potential reach and impact.

More about Lipocine Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 19.392 mill. $ 1.569 mill. $ -11.851 mill.


Lunai Bioworks Inc
Share Performance



+7.88%
30 Days
Lunai Bioworks Inc
Profile

Lunai Bioworks is a pre-clinical biotechnology company focused on developing cell, gene, and immunotherapy treatments for cancer.

More about Lunai Bioworks Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 8.123 mill. $ 0.021 mill. $ -128.284 mill.


Longeveron Inc
Share Performance



-3.62%
Over The Past 5 Days
Longeveron Inc
Profile

Longeveron Inc's business model involves the development and commercialization of regenerative medicine products using mesenchymal stem cells for various medical conditions.

More about Longeveron Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 208.661 mill. $ 1.187 mill. $ -23.474 mill.

38 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: International Stem Cell Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on International Stem Cell Corporation versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.